Given the above, we propose that the overexpression of R-RAS2 may be an important event in the initiation of the neural transformation process in low grade CNS tumors, in which the PTEN/PI3K pathway has still to be activated due to mutation. Here, RRAS2 is linked to central nervous system neoplasm.